Dyrness Albert D.

CIK 00016648013 companiesNEW YORK, NY

Transactions

Companies

Filings

CIK

0001664801

Recent Transactions

14 trades

Award
Hyperliquid Strategies Inc$PURR
Common Stock
2026-02-09+40,789→ 41,671 total
Disposition to Issuer
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2025-12-02−4,537→ 0 total
Other
Hyperliquid Strategies Inc$PURR
Common Stock
2025-12-02+882→ 882 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-12-11+373→ 537 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-07-11+4,000→ 4,537 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-05-30$0.47/sh+23,255→ 28,962 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2022-12-14+3,770→ 30,893 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2021-12-15+14,152→ 27,123 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-07-02+8,005→ 12,971 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-06-11$4.01/sh+2,409→ 4,966 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Warrant to Purchase Common Stock
2020-04-01+1,279→ 1,279 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-04-01+2,557→ 2,557 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2017-10-26+15,000→ 15,000 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2016-12-22+11,500→ 11,500 total

C/O HYPERLIQUID STRATEGIES INC 477 MADISON AVENUE, 22ND FLOOR

NEW YORK, NY, 10022